What this instrument covers
The National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment (April Update) Instrument 2026 updates the rules governing how chemotherapy medicines are funded under the Pharmaceutical Benefits Scheme (PBS). The instrument amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024 (PB 31 of 2024).
Authorising legislation
The instrument is authorised under the National Health Act 1953 and was registered on 31 March 2026.
Dates
- Registered: 31 March 2026
- Repealed: 18 August 2026
The instrument was in force from 31 March 2026 to 18 August 2026, at which point it was repealed.
What changed
The source document does not specify the particular changes made to the chemotherapy funding arrangements by this amendment.
Key actions
- Pharmacies and oncology-related health services that dispense PBS-funded chemotherapy can check the updated National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024 (PB 31 of 2024) on the Federal Register of Legislation at legislation.gov.au to confirm any changes to eligible medicines or funding conditions that applied between 31 March 2026 and 18 August 2026.
- The full instrument text and explanatory statement are available at legislation.gov.au/F2026L00404 for details of exactly what schedule amendments were made.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.